Vectura Group (VEC) Share Price

Health Care Sector

  1. Home
    2. /
  2. Company
    3. /
  3. Vectura Group

NOTE: This is based on 127 open tips for Vectura Group (VEC)


Vectura Group (VEC)
Latest Quote Price

164.80p

Vectura Group (VEC)
Price Change (%)

0.12%


Latest Bid : 164.60p Latest Ask : 165.00p
High Today : 165.00p Low Today : 164.60p
This Years High : 173.00p This Years Low : 102.60p
Volume : 68,784 MKT Cap : £1010.22M
Trading Velocity : Premium Only Activity Score : Premium Only
Consensus Score : Premium Only Momentum Score : Premium Only

Vectura Group (VEC) Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition
for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development,
including small molecules and biologics, complex combinations and generic products.

Vectura Group (VEC) Latest Tips

Type Tipster SectorScore Start date Performance
Overweight JP Morgan Premium Only 2019-04-03 15:50:00 03/04/2019 22.97%
Hold Peel Hunt Premium Only 2019-04-02 11:20:00 02/04/2019 40.52%
Hold Shore Capital Premium Only 2019-03-26 11:05:00 26/03/2019 151.19%
Hold Peel Hunt Premium Only 2019-03-26 09:10:00 26/03/2019 38.60%
Hold Peel Hunt Premium Only 2019-03-12 10:10:00 12/03/2019 35.31%

Premium Content

You are missing Premium Content from this chart

Please Log In to a premium account or Sign Up today to view premium content.


Vectura Group (VEC) Active Short Positions

Fund Manager Position Date
No active short positions

See more short positions...


Latest Bid : 164.60p Latest Ask : 165.00p
High Today : 165.00p Low Today : 164.60p
This Years High : 173.00p This Years Low : 102.60p
Volume : 68,784 MKT Cap : £1010.22M

Vectura Group Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition
for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development,
including small molecules and biologics, complex combinations and generic products.

NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.


Latest Vectura Group Tips

Type Tipster SectorScore Start date Performance
Overweight JP Morgan Premium Only 2019-04-03 15:50:00 03/04/2019 22.97%
Hold Peel Hunt Premium Only 2019-04-02 11:20:00 02/04/2019 40.52%
Hold Shore Capital Premium Only 2019-03-26 11:05:00 26/03/2019 151.19%
Hold Peel Hunt Premium Only 2019-03-26 09:10:00 26/03/2019 38.60%
Hold Peel Hunt Premium Only 2019-03-12 10:10:00 12/03/2019 35.31%